Outlook Therapeutics, Inc.

Q: Jun 30 2026

Q: Jun 30 2026

Q: Mar 31 2026

Q: Dec 31 2025

FY: Sep 30 2025

Q: Jun 30 2025

Q: Mar 31 2025

Q: Dec 31 2024

FY: Sep 30 2024

FY: Sep 30 2024

Q: Jun 30 2024

Q: Mar 31 2024

Q: Dec 31 2023

FY: Sep 30 2023

FY: Sep 30 2023

Q: Jun 30 2023

Q: Mar 31 2023

Q: Dec 31 2022

FY: Sep 30 2022

FY: Sep 30 2022

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Other Events

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Other Events

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Other Events

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Other Events

Other Events

Other Events

Other Events

Other Events

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Unregistered Sales of Equity Securities

Other Events

Other Events

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Rule 506(b) provides a "safer harbor" for a private offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Registration statement under Securities Act of 1933

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Definitive Proxy Statement

Preliminary Proxy Statement

Definitive Proxy Statement

Additional Information for Proxy Statement/ Votes

Definitive Proxy Statement

Lundquist Kevin Michael

Lundquist Kevin Michael

CVI Investments, Inc.

KENYON LAWRENCE A

Jahr Robert Charles

GMS Ventures & Investments

Sukhtian Ghiath M.; GMS Ventures & Investments

Sukhtian Faisal Ghiath

Jahr Robert Charles

KENYON LAWRENCE A

Haddadin Yezan Munther

Sukhtian Ghiath M.; GMS Ventures & Investments

GMS Ventures & Investments

THURMAN RANDY H

HILZINGER KURT J

Haddadin Yezan Munther

Sukhtian Faisal Ghiath

INTRACOASTAL CAPITAL, LLC

SPHERA FUNDS MANAGEMENT LTD.

Empery Asset Management, LP

Draft registration statement (confidential submission)

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Annual Report Scanned (Paper)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC